Enteral Nutrition in Patients with Inflammatory Bowel Disease. Systematic Review, Meta-Analysis, and Meta-Regression

Overview

Journal Nutrients

Date 2019 Nov 7

PMID 31689999

Citations 11

Authors

Jose M Comeche

Pablo Caballero

Ana Gutierrez-Hervas

Sofia Garcia-Sanjuan

Iris Comino

Cesare Altavilla

Jose Tuells

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is a chronic disease mediated by the immune system and is characterized by inflammation of the gastrointestinal tract. One of the possible treatments for this pathology is a change in the type of diet, of which enteral nutrition (EN) is one. This study is to understand how the use of EN can affect the adult population diagnosed with IBD. We conducted a systematic review, meta-analysis, and a meta-regression. On the different databases (MEDLINE, Scopus, Cochrane, LILACS, CINAHL, WOS), we found 363 registers with an accuracy of 12% (44 registers). After a full-text review, only 30 research studies were selected for qualitative synthesis and 11 for meta-analysis and meta-regression. The variables used were Crohn's disease activity index (CDAI), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). EN has been shown to have efficacy for the treatment of Crohn's disease and is compatible with other medicines. As for the CDAI or rates of remission, there were no differences between enteral and parenteral nutrition. Polymeric formulas have shown better results with respect to the CRP. The long-term treatment could dilute the good CDAI results that are obtained at the start of the EN treatment.

Citing Articles

Nutritional Status and Nutritional Support in Patients with Gastrointestinal Diseases.

Jablonska B Nutrients. 2025; 17(2.

PMID: 39861400 PMC: 11767507. DOI: 10.3390/nu17020270.

The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review.

Nieva C, Pryor J, Williams G, Hoedt E, Burns G, Eslick G J Crohns Colitis. 2023; 18(6):920-942.

PMID: 38102104 PMC: 11147801. DOI: 10.1093/ecco-jcc/jjad204.

Diet and microbiome in the beginning of the sequence of gut inflammation.

Ceballos D, Hernandez-Camba A, Ramos L World J Clin Cases. 2022; 9(36):11122-11147.

PMID: 35071544 PMC: 8717522. DOI: 10.12998/wjcc.v9.i36.11122.

Enteral nutrition ameliorates the symptoms of Crohn's disease in mice via activating special pro-resolving mediators through innate lymphoid cells.

Zhao D, Yang B, Ye C, Zhang S, Lv X, Chen Q Innate Immun. 2021; 27(7-8):533-542.

PMID: 34791916 PMC: 8762089. DOI: 10.1177/17534259211057038.

Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract.

Ber Y, Garcia-Lopez S, Gargallo-Puyuelo C, Gomollon F Nutrients. 2021; 13(7).

PMID: 34371835 PMC: 8308711. DOI: 10.3390/nu13072325.

References

Mansfield J, Giaffer M, HOLDSWORTH C . Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut. 1995; 36(1):60-6. PMC: 1382354. DOI: 10.1136/gut.36.1.60. View

Griffiths A . Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr. 2005; 29(4 Suppl):S108-12. DOI: 10.1177/01486071050290S4S108. View

Guo Z, Wu R, Zhu W, Gong J, Zhang W, Li Y . Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease. Nutr Clin Pract. 2013; 28(4):499-505. DOI: 10.1177/0884533613487218. View

Abad-Lacruz A, Gonzalez-Huix F, Esteve M, Fernandez-Banares F, Cabre E, Boix J . Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1990; 14(6):618-21. DOI: 10.1177/0148607190014006618. View

Tan S, Yu C, Yu Z, Lin Z, Wu G, Yu W . High-fat enteral nutrition reduces intestinal mucosal barrier damage after peritoneal air exposure. J Surg Res. 2016; 202(1):77-86. DOI: 10.1016/j.jss.2015.12.010. View

Fell J, Paintin M, Arnaud-Battandier F, Beattie R, Hollis A, Kitching P . Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000; 14(3):281-9. DOI: 10.1046/j.1365-2036.2000.00707.x. View

Celiberto L, Graef F, Healey G, Bosman E, Jacobson K, Sly L . Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology. 2018; 155(1):36-52. PMC: 6099178. DOI: 10.1111/imm.12939. View

Teahon K, Smethurst P, Pearson M, Levi A, Bjarnason I . The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology. 1991; 101(1):84-9. DOI: 10.1016/0016-5085(91)90463-u. View

Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K . Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr. 2002; 26(2):98-103. DOI: 10.1177/014860710202600298. View

10.

Raouf A, Hildrey V, Daniel J, Walker R, Krasner N, Elias E . Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut. 1991; 32(6):702-7. PMC: 1378894. DOI: 10.1136/gut.32.6.702. View

11.

Feng Y, Li Y, Mei S, Zhang L, Gong J, Gu L . Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease. Clin Nutr. 2013; 33(5):850-8. DOI: 10.1016/j.clnu.2013.10.009. View

12.

Bamba T, Shimoyama T, Sasaki M, Tsujikawa T, Fukuda Y, Koganei K . Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol. 2003; 15(2):151-7. DOI: 10.1097/00042737-200302000-00008. View

13.

Royall D, Greenberg G, Allard J, Baker J, Jeejeebhoy K . Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN J Parenter Enteral Nutr. 1995; 19(2):95-9. DOI: 10.1177/014860719501900295. View

14.

Papi C, Fasci-Spurio F, Rogai F, Settesoldi A, Margagnoni G, Annese V . Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors. Dig Liver Dis. 2013; 45(12):978-85. DOI: 10.1016/j.dld.2013.07.006. View

15.

Ruemmele F . Role of Diet in Inflammatory Bowel Disease. Ann Nutr Metab. 2016; 68 Suppl 1:33-41. DOI: 10.1159/000445392. View

16.

Scolapio J . The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol. 1999; 29(3):223-4. DOI: 10.1097/00004836-199910000-00002. View

17.

Ruemmele F, Roy C, Levy E, Seidman E . Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy?. J Pediatr. 2000; 136(3):285-91. DOI: 10.1067/mpd.2000.104537. View

18.

Forbes A, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S . ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017; 36(2):321-347. DOI: 10.1016/j.clnu.2016.12.027. View

19.

Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Iwabuchi M, Takahashi H . Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial. Aliment Pharmacol Ther. 2006; 24(9):1333-40. DOI: 10.1111/j.1365-2036.2006.03120.x. View

20.

Guagnozzi D, Gonzalez-Castillo S, Olveira A, Lucendo A . Nutritional treatment in inflammatory bowel disease. An update. Rev Esp Enferm Dig. 2012; 104(9):479-88. DOI: 10.4321/s1130-01082012000900006. View